The FDA has identified this as a Class I recall, the most serious type of recall. There have been 13 reported injuries. There have been no reports of death. Get the Strategy to Trade Pre-Fed Setups ...

In November 2023, the FDA informed that it is evaluating the potential for device failures with plastic syringes manufactured in China. The FDA received over 4,000 reports concerning problems with ...

LE PONT-DE-CLAIX, France, Sept. 18, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial release of the BD Neopak™ ...

May 2 (Reuters) - Becton Dickinson (BDX.N), opens new tab raised its annual profit forecast and beat second-quarter profit estimates on Thursday, as the group banks on strong demand for its surgical ...

March 21 (Reuters) - Becton Dickinson BDX.N said on Thursday that it will increase production of medical syringes in the United States. The company said since the initial U.S. Food and Drug ...

(Reuters) -Becton Dickinson said on Thursday it has increased production of medical syringes in the United States after the country's drug regulator recommended not using some China-made syringes as ...

Becton, Dickinson and Company has the launched BD Emerald Syringe set of products that contain less material to address environmental impact, according to a news release by the company. The new ...

Analyst Nico Chen of DBS maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price target of $285.00. Nico Chen has given his Buy rating due to a combination of factors that ...

Becton, Dickinson and Co. has announced it will acquire Safety Syringes, according to a news release. Safety Syringes, headquartered in Carlsbad, Calif., develops anti-needlestick devices for ...

(Reuters) - A U.S. federal court has ordered medical device maker Becton Dickinson and Co to notify customers that it falsely claimed its safety syringes were sharper and wasted less medicine than ...

Becton Dickinson (NYSE:BDX) said it plans to make additional investments in its U.S. manufacturing network to add capacity for the production of critical medical devices such as syringes, needles and ...